Evidence map›Paper›PMID 21333271›Full record

ArticleArchives of oral biology2011

Short- and medium-chain fatty acids exhibit antimicrobial activity for oral microorganisms.

Chifu B Huang, Yelena Alimova, Taylor M Myers, Jeffrey L Ebersole

Abstract read
In one paragraph

Article in Archives of oral biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Genetic modification ofApplied and environmental microbiology · 2026
    Article
  7. Article
  8. Article
  9. Macroscopic Markers of Dolphin Healing at Sea Linked to Immunity.Animals : an open access journal from MDPI · 2026
    Article
  10. Review
  11. The role ofFrontiers in oral health · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chifu B HuangCenter for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, KY 40503, United States. chuan2@uky.edu
Yelena Alimova
Taylor M Myers
Jeffrey L Ebersole

Funding

Identification of anti-cariogenic/low-glycemic activity factors from Lo Han KuoR41DE017265 · NIDCR · ORACEUTICALS, INC. · PI HUANG, CHIFU BRAD · 2006 to 2006
$100k
NIDCR NIH HHS R41 DE017265NIDCR NIH HHS R41DE17265-01
6 · The paper itself

Abstract

objectivesThis study assessed the antibacterial activity of short-, medium-, and long-chain fatty acids against various oral microorganisms.

methodsThe short-chain fatty acids [formic acid (C1), acetic acid (C2), propionic acid (C3), butyric acid (C4), isobutyric acid (C4), isovaleric acid (C5), hexanoic acid (C6)], medium-chain fatty acids [octanoic acid (C8), capric acid (C10), lauric acid (12)], and long-chain fatty acids [myristic acid (C14), palmitic acid (C16)], were investigated for antimicrobial activity against Streptococcus mutans, Streptococcus gordonii, Streptococcus sanguis, Candida albicans, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Porphyromonas gingivalis.

resultsThe data demonstrated that the fatty acids exhibited patterns of inhibition against oral bacteria with some specificity that appeared related more to the bacterial species that the general structural characteristics of the microorganism. As a group the fatty acids were much less effective against C. albicans than the oral bacteria, with effectiveness limited to hexanoic, octanoic, and lauric acids. Formic acid, capric, and lauric acids were broadly inhibitory for the bacteria. Interestingly, fatty acids that are produced at metabolic end-products by a number of these bacteria, were specifically inactive against the producing species, whilst substantially inhibiting the growth of other oral microorganisms.

conclusionsThe results indicate that the antimicrobial activity of short-chain fatty acids (SCFAs), medium-chain fatty acids (MCFAs), long-chain fatty acids (LCFAs) could influence the microbial ecology in the oral cavity via at least 2 potential pathways. First, the agents delivered exogenously as therapeutic adjuncts could be packaged to enhance a microbial-regulatory environment in the subgingival sulcus. Second, it would be the intrinsic nature of these fatty acid inhibitors in contributing to the characteristics of the microbial biofilms, their evolution, and emergence of species within the biofilms. Further studies on these functions are required to better understand the nature of these potential microbial interactions in the biofilms.

Indexed as

Acetic AcidAggregatibacter actinomycetemcomitansAnti-Infective AgentsBiofilmsButyric AcidCandida albicansCaproatesCaprylatesDecanoic AcidsFatty AcidsFatty Acids, VolatileFormatesFusobacterium nucleatumHemiterpenesHumansIsobutyratesAcetic AcidAnti-Infective AgentsButyric AcidCaproatesCaprylatesdecanoic acidDecanoic AcidsFatty AcidsFatty Acids, VolatileFormatesformic acidHemiterpeneshexanoic acidIsobutyratesisobutyric acidisovaleric acidlauric acidLauric AcidsMyristic Acidoctanoic acidPalmitic AcidPentanoic AcidsPropionatespropionic acid

Identifiers

PMID21333271
PMCPMC3119748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.